Cargando…

MARGINAL: An Automatic Classification of Variants in BRCA1 and BRCA2 Genes Using a Machine Learning Model

Implementation of next-generation sequencing (NGS) for the genetic analysis of hereditary diseases has resulted in a vast number of genetic variants identified daily, leading to inadequate variant interpretation and, consequently, a lack of useful clinical information for treatment decisions. Herein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karalidou, Vasiliki, Kalfakakou, Despoina, Papathanasiou, Athanasios, Fostira, Florentia, Matsopoulos, George K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687470/ https://www.ncbi.nlm.nih.gov/pubmed/36358902 http://dx.doi.org/10.3390/biom12111552

Ejemplares similares

CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects
por: Apostolou, Paraskevi, et al.
Publicado: (2021)

A Paternally Inherited BRCA1 Mutation Associated with an Unusual Aggressive Clinical Phenotype
por: Fostira, Florentia, et al.
Publicado: (2014)

Gene-specific machine learning for pathogenicity prediction of rare BRCA1 and BRCA2 missense variants
por: Kang, Moonjong, et al.
Publicado: (2023)

Consistency of BRCA1 and BRCA2 Variant Classifications Among Clinical Diagnostic Laboratories
por: Lincoln, Stephen E., et al.
Publicado: (2017)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance
por: Iversen, Edwin S., et al.
Publicado: (2022)

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
por: Li, Shuai, et al.
Publicado: (2022)

Gene-specific machine learning model to predict the pathogenicity of BRCA2 variants
por: Khandakji, Mohannad N., et al.
Publicado: (2022)

Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in BRCA1 and BRCA2
por: Hwang, Sang Mee, et al.
Publicado: (2018)

Value of the loss of heterozygosity to BRCA1 variant classification
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2022)

Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
por: Hart, Steven N., et al.
Publicado: (2020)

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
por: O’Mahony, Denise G., et al.
Publicado: (2023)

Comparison of locus-specific databases for BRCA1 and BRCA2 variants reveals disparity in variant classification within and among databases
por: Vail, Paris J., et al.
Publicado: (2015)

Accurate classification of BRCA1 variants with saturation genome editing
por: Findlay, Gregory M., et al.
Publicado: (2018)

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
por: Parsons, Michael T., et al.
Publicado: (2019)

Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases
por: Stavropoulou, Alexandra V., et al.
Publicado: (2013)

BRCA1-specific machine learning model predicts variant pathogenicity with high accuracy
por: Khandakji, Mohannad, et al.
Publicado: (2023)

Systematic misclassification of missense variants in BRCA1 and BRCA2 “coldspots”
por: Dines, Jennifer N., et al.
Publicado: (2020)

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
por: Hakkaart, Christopher, et al.
Publicado: (2022)

Correction: Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases
por: Stavropoulou, Alexandra V., et al.
Publicado: (2013)

One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene
por: Fostira, Florentia, et al.
Publicado: (2020)

Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants
por: Momozawa, Yukihide, et al.
Publicado: (2022)

Melanoma predisposition—A limited role for germline BRCA1 and BRCA2 variants
por: Adams, David J., et al.
Publicado: (2019)

BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies
por: Lee, Anbok, et al.
Publicado: (2020)

Dual BRCA1 and BRCA2 pathogenic variants in an adolescent with syndromic intellectual disability
por: Algouneh, Arash, et al.
Publicado: (2022)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
por: Ferreyra, Yomali, et al.
Publicado: (2023)

Toward Classification of BRCA1 Missense Variants Using a Biophysical Approach
por: Rowling, Pamela J. E., et al.
Publicado: (2010)

Sequencing-based functional assays for classification of BRCA2 variants in mouse ESCs
por: Biswas, Kajal, et al.
Publicado: (2023)

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
por: Keshavarzi, F, et al.
Publicado: (2011)

Missense Variants of Uncertain Significance (VUS) Altering the Phosphorylation Patterns of BRCA1 and BRCA2
por: Tram, Eric, et al.
Publicado: (2013)

Identification of Recurrent Variants in BRCA1 and BRCA2 across Multiple Cancers in the Chinese Population
por: Jiang, Yue, et al.
Publicado: (2020)

In silico analysis of BRCA1 and BRCA2 missense variants and the relevance in molecular genetic testing
por: Poon, Kok-Siong
Publicado: (2021)

Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
por: Edaily, Sarah, et al.
Publicado: (2022)

Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2018)

Clinically Significant Unclassified Variants in BRCA1 and BRCA2 genes among Korean Breast Cancer Patients
por: Yoon, Kyong-Ah, et al.
Publicado: (2017)

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
por: Kast, Karin, et al.
Publicado: (2023)

BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories
por: Hovland, Henrikke N., et al.
Publicado: (2022)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

The Clinical Significance of Unknown Sequence Variants in BRCA Genes
por: Calò, Valentina, et al.
Publicado: (2010)

Clinical significance of variants of unknown significances in BRCA genes
por: Choi, Min Chul
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_asuubm2hvpgh6sqjaoa2cf9028